Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Click to expand full analysis sheet
Initially developed for obesity treatment, AOD9604 showed weight-reducing effects in rodent models comparable to those of full-length GH, but without inducing diabetes or stimulating IGF-1 production
Supplied as lyophilised solid at 98% purity (HPLC verified) , UK-dispatched by OL Research
Cyanocobalamin injections are common for standard B12 deficiency treatment
Consequently, it is preferred by many of the medical directors with whom we work as a means of providing metabolic assistance without causing the traditional side effects such as heart palpitations and jitters seen with stimulants containing caffeine, (e.g., sympathomimetic drugs)
Research has confirmed no significant effects on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no immunogenicity with no anti-AOD-9604 antibodies detected in any participants
US$ 28.07
US$ 27.71
US$ 20.03
US$ 20.22
